Atabak Mokari
Chief Financial Officer · 7 filings · Latest: Sep 1, 2026
CORCEPT THERAPEUTICS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CORT | Atabak Mokari | Chief Financial Officer | Jul 30, 2026 | Sale | $114.71 | 80,000 | $9.2M | 16,130 | |
CORT | Atabak Mokari | Chief Financial Officer | Jul 30, 2026 | Option Exercise | $23.06 | 80,000 | $1.8M | 96,130 | |
CORT | Mokari Atabak | — | Jul 30, 2026 | Proposed Sale | $114.71 | 40,000 | $4.6M | — | |
CORT | Atabak Mokari | Chief Financial Officer | Jul 15, 2026 | Sale | $87.71 | 40,000 | $3.5M | 16,130 | |
CORT | Atabak Mokari | Chief Financial Officer | Jul 15, 2026 | Option Exercise | $21.56 | 40,000 | $862.2K | 56,130 | |
CORT | Atabak Mokari | Chief Financial Officer | Jun 15, 2026 | Sale | $81.15 | 40,000 | $3.2M | 16,130 | |
CORT | Atabak Mokari | Chief Financial Officer | Jun 15, 2026 | Option Exercise | $19.26 | 40,000 | $770.4K | 56,130 | |
CORT | Atabak Mokari | Chief Financial Officer | Jun 1, 2026 | Sale | $70.00 | 40,000 | $2.8M | 15,257 | |
CORT | Atabak Mokari | Chief Financial Officer | Jun 1, 2026 | Option Exercise | $19.26 | 40,000 | $770.4K | 55,257 | |
CORT | Mokari Atabak | — | Jun 1, 2026 | Proposed Sale | $70.00 | 160,000 | $11.2M | — |